Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 255,865 | 421,414 | 463,156 | 352,861 | 204,095 |
| Receivables | 509,364 | 464,892 | 474,643 | 554,859 | 528,039 |
| Inventories | 474,821 | 478,006 | 416,915 | 358,772 | 377,784 |
| TOTAL | $1,451,485 | $1,542,609 | $1,523,459 | $1,469,758 | $1,300,485 |
| Non-Current Assets | |||||
| PPE Net | 459,472 | 424,819 | 417,335 | 397,209 | 408,364 |
| Intangibles | 2,323,490 | 2,332,637 | 2,338,492 | 2,349,421 | 2,351,508 |
| Other Non-Current Assets | 338,409 | 320,779 | 308,090 | 294,155 | 293,582 |
| TOTAL | $3,121,371 | $3,078,235 | $3,063,917 | $3,040,785 | $3,053,454 |
| Total Assets | $4,572,856 | $4,620,844 | $4,587,376 | $4,510,543 | $4,353,939 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 122,166 | 117,589 | 135,786 | 116,148 | 114,322 |
| Accrued Expenses | 280,332 | 269,859 | 270,353 | 235,201 | 217,847 |
| TOTAL | $577,335 | $590,853 | $602,761 | $551,519 | $500,045 |
| Non-Current Liabilities | |||||
| Long Term Debt | 813,732 | 1,044,435 | 1,164,133 | 1,364,849 | 1,287,509 |
| Deferred Revenues | 105,238 | 102,035 | 98,617 | 97,110 | 92,950 |
| aiOther Non-Current Liabilities | 217,173 | 209,802 | 223,137 | 227,688 | 194,430 |
| TOTAL | $1,130,537 | $1,351,131 | $1,487,588 | $1,702,593 | $1,595,788 |
| Total Liabilities | $1,707,872 | $1,941,984 | $2,090,349 | $2,254,112 | $2,095,833 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,509 | 144,915 | 144,901 | 144,668 | 144,617 |
| Common Shares | 582 | 580 | 580 | 579 | 578 |
| Retained earnings | 3,076,569 | 2,953,709 | 2,832,991 | 2,711,639 | 2,604,910 |
| Other shareholders' equity | -163,407 | -240,447 | -284,238 | -366,692 | -246,374 |
| TOTAL | $2,864,984 | $2,678,860 | $2,497,027 | $2,256,431 | $2,258,106 |
| Total Liabilities And Equity | $4,572,856 | $4,620,844 | $4,587,376 | $4,510,543 | $4,353,939 |